Jak Knowles (L) and Dirk Nagorsen (Affini-T)
'Go quickly': Amgen R&D vet Dirk Nagorsen jumps to a startup with big plans for TCRs
You can call it the summer of inception at Affini-T Therapeutics, the TCR upstart out of the Fred Hutch.
Born with a trio of distinguished …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
